Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTUS
1826
DELISTED
Natus Medical Inc
NTUS
| $1.61M | ﹤0.01% |
62,800
+1,200
| +2% | +$30.6K |
|
1827
Baytex Energy
BTE
$3.06B
| $1.61M | ﹤0.01% |
1,037,776
+28,100
| +3% | +$51K |
|
1828
Angi Inc
ANGI
$186M
| $1.61M | ﹤0.01% |
12,350
+750
| +6% | +$116K |
|
|
SPPI
1829
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.6M | ﹤0.01% |
186,000
+10,600
| +6% | +$94.8K |
|
1830
Upwork
UPWK
$1.21B
| $1.6M | ﹤0.01% |
+99,300
| New | +$1.71M |
|
1831
Central Pacific Financial
CPF
$991M
| $1.59M | ﹤0.01% |
53,200
| – | – |
|
|
ALX
1832
Alexander's
ALX
$1.38B
| $1.59M | ﹤0.01% |
4,300
+100
| +2% | +$38K |
|
1833
Bally's
BALY
$637M
| $1.59M | ﹤0.01% |
+53,500
| New | +$1.67M |
|
1834
Caleres
CAL
$486M
| $1.59M | ﹤0.01% |
79,800
+1,100
| +1% | +$25.4K |
|
1835
Genesco
GCO
$419M
| $1.59M | ﹤0.01% |
37,600
+800
| +2% | +$35.4K |
|
1836
Mesa Laboratories
MLAB
$569M
| $1.59M | ﹤0.01% |
6,502
+200
| +3% | +$46.6K |
|
|
RTEC
1837
DELISTED
Rudolph Technologies Inc
RTEC
| $1.59M | ﹤0.01% |
57,500
-700
| -1% | -$17.1K |
|
|
CARB
1838
DELISTED
Carbonite Inc
CARB
| $1.59M | ﹤0.01% |
61,000
+1,200
| +2% | +$29.3K |
|
1839
Standard BioTools
LAB
$310M
| $1.58M | ﹤0.01% |
+128,300
| New | +$1.63M |
|
1840
CTS Corp
CTS
$1.85B
| $1.58M | ﹤0.01% |
57,300
| – | – |
|
|
DMC
1841
Del Monte Corp
DMC
$1.43B
| $1.58M | ﹤0.01% |
58,600
+1,900
| +3% | +$51.9K |
|
|
SAFE
1842
Safehold
SAFE
$1.09B
| $1.57M | ﹤0.01% |
26,050
+596
| +2% | +$28.5K |
|
1843
Greif
GEF
$4.97B
| $1.57M | ﹤0.01% |
48,200
+900
| +2% | +$33.5K |
|
1844
Andersons Inc
ANDE
$2.23B
| $1.56M | ﹤0.01% |
57,450
+8,400
| +17% | +$250K |
|
|
AVX
1845
DELISTED
AVX Corporation
AVX
| $1.56M | ﹤0.01% |
94,200
+1,900
| +2% | +$31.3K |
|
1846
1st Source
SRCE
$2.1B
| $1.56M | ﹤0.01% |
33,689
+600
| +2% | +$27.5K |
|
|
CTWS
1847
DELISTED
Connecticut Water Service Inc
CTWS
| $1.56M | ﹤0.01% |
22,400
+500
| +2% | +$34.6K |
|
|
EVRI
1848
DELISTED
Everi Holdings
EVRI
| $1.56M | ﹤0.01% |
130,600
+2,700
| +2% | +$29.3K |
|
|
THR
1849
DELISTED
Thermon Group Holdings
THR
| $1.56M | ﹤0.01% |
60,700
+1,300
| +2% | +$32.4K |
|
1850
Kelly Services Class A
KELYA
$544M
| $1.56M | ﹤0.01% |
59,400
+1,300
| +2% | +$31.1K |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.